Search research articles
Contact Us
Filters
Showing results (51-60 of 626) with videos related to
Page
of 63
Sort By:
Anti-Cancer Drugs
|
August 13, 2002
Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action
Gregory J Aune, Takahisa Furuta, Yves Pommier
Oncotarget
|
January 17, 2019
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
Yves Pommier, Mark Cushman, James H Doroshow
Journal of Medicinal Chemistry
|
April 29, 2005
On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex
Xiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Total synthesis and biological evaluation of 22-hydroxyacuminatine
Xiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Nucleic Acids Research
|
February 28, 2002
Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase
Laurent Debéthune, Glenda Kohlhagen, Anna Grandas, et al.
The Journal of Biological Chemistry
|
April 19, 2015
Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites
Shar-Yin Naomi Huang, Sanchari Ghosh, Yves Pommier
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
A novel diketo phosphonic acid that exhibits specific, strand-transfer inhibition of HIV integrase and anti-HIV activity
Guochen Chi, Vasu Nair, Elena Semenova, et al.
Chemistry & Biology
|
June 11, 2010
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
Yves Pommier, Elisabetta Leo, HongLiang Zhang, et al.
Current Topics in Medicinal Chemistry
|
February 7, 2003
Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy
Ling-Hua Meng, Zhi-Yong Liao, Yves Pommier
Expert Opinion on Therapeutic Patents
|
August 17, 2011
Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors
Shar-yin N Huang, Yves Pommier, Christophe Marchand
Page
of 63
Search research articles
Search
Showing results (51-60 of 626) with videos related to
Sort By:
Page
of 63
Anti-Cancer Drugs
|
August 13, 2002
Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action
Gregory J Aune, Takahisa Furuta, Yves Pommier
Oncotarget
|
January 17, 2019
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
Yves Pommier, Mark Cushman, James H Doroshow
Journal of Medicinal Chemistry
|
April 29, 2005
On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex
Xiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Total synthesis and biological evaluation of 22-hydroxyacuminatine
Xiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Nucleic Acids Research
|
February 28, 2002
Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase
Laurent Debéthune, Glenda Kohlhagen, Anna Grandas, et al.
The Journal of Biological Chemistry
|
April 19, 2015
Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites
Shar-Yin Naomi Huang, Sanchari Ghosh, Yves Pommier
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
A novel diketo phosphonic acid that exhibits specific, strand-transfer inhibition of HIV integrase and anti-HIV activity
Guochen Chi, Vasu Nair, Elena Semenova, et al.
Chemistry & Biology
|
June 11, 2010
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
Yves Pommier, Elisabetta Leo, HongLiang Zhang, et al.
Current Topics in Medicinal Chemistry
|
February 7, 2003
Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy
Ling-Hua Meng, Zhi-Yong Liao, Yves Pommier
Expert Opinion on Therapeutic Patents
|
August 17, 2011
Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors
Shar-yin N Huang, Yves Pommier, Christophe Marchand
Page
of 63